Hepatitis Drug Continues Record Sales

Gilead Sciences’s new hepatitis C treatment, Sovaldi, had $3.48 billion in second-quarter sales, more than expected, continuing its historic drug launch.

from WSJ.com: What’s News US http://ift.tt/1tBxeDe
via IFTTT

Online Video Blitz Gets Weird Al Yankovic To #1 on the Billboard 200

After 14 attempts over 31 years, Weird Al Yankovic has finally reached number one in the Billboard album charts. Mandatory Fun will debut at number one on the Billboard 200 based on sales from last week. Yankovic had previously said it’s likely to be his last album and he’ll now concentrate on singles and music […]

from Geeks are Sexy Technology News http://ift.tt/1ufgo1h
via IFTTT